Material Type

• Blood (whole) (2)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (3)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Plasma (double spun) (1)
• Plasma (single spun) (4)
• Saliva (3)
• Serum (5)
• Stool (1)
• Swab medium (2)
• Urine (random) (2)

Microscopic Assessment

• Not applicable (6)

Storage Temperature

• -35°C to -18°C (1)
• -85°C to -60°C (6)
• Liquid nitrogen (1)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (5)
• Followup records (4)
• Freezer temperature logs (1)
• Genomic datasets (1)
• Microbiological results (4)
• Participant Ethnicity (1)
• Physiological/biochemical measurements (2)
• Pre-analytical data (3)
• Quality indicators (2)
• Survey data (4)
• Treatment records (2)

Timeframe

• 0 - 3 months (6)
• 3 - 6 months (2)
• > 6 months (1)

Participant Count

• 1 - 10 (1)
• 11 - 100 (3)
• 101 - 500 (4)
• 1001 - 3000 (1)

Sex

• Both sexes (6)

Age Range

• Young adult (18 - 40 years) (6)

Biobank Services

• Ability to recontact (2)
• Cell culture (2)
• Data analytics (2)
• Molecular Extractions (1)
• Nucleic acid extraction (1)

Collection Type

• Case-control (2)
• Cross-sectional (2)
• Disease specific (3)

Consent Restriction

• No Commercial restriction (6)
• No Disease area restriction (6)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (6)
• No restrictions (2)
• No Project specific restriction (6)
• No Scope of use restriction (4)

Collection Status

• Completed (3)
• In progress (3)
• Not-started (1)

Access Condition

• Open to applicants (5)
• Open only through collaboration (1)

Country

• Belgium (1)
• France (1)
• Kenya (1)
• Peru (1)
• South Africa (1)
• United States (1)

County